Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Christian Rolfo(Icahn School of Medicine at Mount Sinai), David R. Gandara(University of California, Davis), Trever G. Bivona(University of California, San Francisco), Philip C. Mack(UC Davis Comprehensive Cancer Center), Luis E. Raez(Florida International University), Natasha B. Leighl(Princess Margaret Cancer Centre), Janet Freeman‐Daily, Chandra P. Belani(Pennsylvania State University), Charles Swanton(The Francis Crick Institute), Umberto Malapelle(Federico II University Hospital), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Nir Peled(Shaare Zedek Medical Center), Heather A. Wakelee(Palo Alto Institute), Caroline Dive(University of Manchester), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Rafał Dziadziuszko(Gdańsk Medical University), Charu Aggarwal(UPMC Hillman Cancer Center), Daniel S.W. Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Murry W. Wynes(International Association for the Study of Lung Cancer), Tony Mok(Chinese University of Hong Kong), Lecia V. Sequist(Harvard University), Giorgio V. Scagliotti(Ospedale San Luigi Gonzaga), Tetsuya Mitsudomi(Kindai University), Fabrice Barlési(Hôpital Nord), Lynette M. Sholl(Brigham and Women's Hospital), Maximilian Diehn(Stanford University), Chris Abbosh(AstraZeneca (United Kingdom)), Rebecca A. Bunn(Western Washington University)
Cited by 642
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k